Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Business
Corp. News
Latest Headlines
Biotech
Investors
Stock Alerts
IPOs
M&A
Top Stories
Breaking News
Earnings
Canadian
UK
Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Crypto
Cryptocurrency
Blockchain
Markets
Market News
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
US
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health News
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment News
Top Stories
Music News
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium
Intelligent Investor
Biotech Investor
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Novo Nordisk B A/S (NOV.DE)
Novo Nordisk POSEIDON Study Finds High Prevalence Of Cardiovascular Inflammation In CVD Patients
5/26/2026 9:07:38 AM
Novo Nordisk POSEIDON Study Reveals Widespread CV Inflammation In Chronic Kidney Disease Patients
5/26/2026 8:33:37 AM
CHMP Issues Positive Opinion On Novo Nordisk's Wegovy 7.2 Mg For Obesity
5/23/2026 12:24:39 PM
Novo Nordisk's Wegovy Pill Wins CHMP Recommendation For Approval In EU
5/22/2026 11:57:31 AM
CHMP Recommends Novo Nordisk's Wegovy Pill As First Oral GLP-1 For Weight Management In EU
5/22/2026 10:32:49 AM
Novo Nordisk B A/S Q1 Income Climbs
5/6/2026 1:43:17 AM
Novo Nordisk Posts Adj Operating Profit Of DKK 32.858 Bln In Q1
5/6/2026 1:32:30 AM
Weekly Buzz: SNY, REGN Get FDA Nod; It's A No For ABBV, GRCE; LLY Acquires Kelonia
4/24/2026 10:34:13 AM
Novo Nordisk's Oral Semaglutide Shows Superior Blood Sugar Control In Youth-Onset Type 2 Diabetes
4/23/2026 7:06:42 AM
Novo Nordisk's Etavopivat Meets Co-primary Goals In Phase 3 HIBISCUS Trial In Sickle Cell Disease
4/20/2026 6:50:43 AM
Novo Nordisk Partners With OpenAI To Transform Drug Discovery And Delivery
4/14/2026 6:19:31 AM
GLP-1 Drugs Move Up The Leaderboard As Twin Epidemics Continue To Balloon
4/13/2026 4:30:46 AM
Weekly Buzz: SPRY Gains FDA Nod; EU Expands Kerendia Label; LLY Acquires CNTA; BIIB Snaps Up APLS
4/3/2026 5:10:06 AM
Novo Nordisk's Wegovy Approved For Cardiovascular Event Risk Reduction In England
4/1/2026 1:02:57 PM
U.K.'s NICE Endorses Novo Nordisk's Wegovy For Cardiovascular Risk Reduction Beyond Weight Loss
4/1/2026 10:38:46 AM
Novo Nordisk Wins FDA Nod For Awiqli, First Once-Weekly Basal Insulin
3/27/2026 10:14:06 AM
Weekly Buzz: CORT Wins FDA Nod In Cancer; MRK Acquires TERN; INSM Meets Trial Goals But VALN Misses
3/27/2026 9:42:17 AM
Triple-G Agonist UBT251 Lowers HbA1c By Up To 2.16% In Chinese Phase 2 Diabetes Trial
3/25/2026 7:06:46 AM
Novo Nordisk Says Triple Agonist UBT251 Shows Up To 2.16% HbA1c Reduction In Phase 2 Trial
3/25/2026 2:34:03 AM
NVO : Triple Agonist UBT251 Cuts HbA1c By 2.16% In Phase 2 Trial Among Type 2 Diabetes Patients
3/25/2026 2:08:55 AM
1
2
Next
»